Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001415889-24-024627

Options or other derivatives

  • Chief Development Officer acquired 215,774 shares (grant or award)
  • Chief Development Officer returned 215,774 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jalota Deepika Chief Development Officer 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −22,674 0 D
Jalota Deepika Chief Development Officer 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −68,100 0 D
Jalota Deepika Chief Development Officer 2024-08-13 Grant or award · Employee Stock Option (right to buy) +90,774 90,774 D
Jalota Deepika Chief Development Officer 2024-08-13 Returned to the company · Employee Stock Option (right to buy) −125,000 0 D
Jalota Deepika Chief Development Officer 2024-08-13 Grant or award · Employee Stock Option (right to buy) +125,000 125,000 D
Loading xslF345X05/form4-10032024_081022.xml…